Skip to content

Tyra Biosciences, Inc. TYRA Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$39.31M-16.2%-$33.83M-13.3%-$29.87M-6.3%-$28.1M+0.2%-$28.15M-10.1%
$138K+4.5%$132K+0.8%$131K-6.4%$140K-2.1%$143K-0.7%
$7.85M+2.9%$7.63M+0.7%$7.58M+18.8%$6.38M-0.7%$6.42M-4.2%
-$32.57M-37.9%-$23.62M-5.6%-$22.38M+5.5%-$23.68M+7.0%-$25.46M-30.0%
$88K+54.4%$57K+46.2%$39K+25.8%$31K+121%$14K+133%
-$120.24M-450%$34.38M$20.87M-34.8%$32.03M
$160.38M+3,325%$4.68M+624%$647K+11.0%$583K-73.3%$2.19M+210%
$7.57M-$36.54M$8.76M
-$32.66M-37.9%-$23.68M-5.6%-$22.42M+5.4%-$23.71M+6.9%-$25.47M-30.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Tyra Biosciences, Inc. generate?
Tyra Biosciences, Inc. (TYRA) generated -$102.3M in operating cash flow over the trailing twelve months.
What is Tyra Biosciences, Inc.'s free cash flow?
After $215.0K of capital expenditures, Tyra Biosciences, Inc.'s free cash flow was -$102.5M over the trailing twelve months, down 39.0% year over year.
Where does Tyra Biosciences, Inc.'s cash flow data come from?
Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.